Results 181 to 190 of about 1,815,617 (316)

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

open access: yesMolecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller   +17 more
wiley   +1 more source

Activation of a FOXO3-induced cell cycle arrest regulates ferroptosis. [PDF]

open access: yesCell Death Discov
Huang H   +6 more
europepmc   +1 more source

Editorial: Non-cell Cycle Functions of Cell Cycle Regulators

open access: yesFrontiers in Cell and Developmental Biology, 2019
Song-Tao Liu, Gordon K. Chan, Weimin Li
openaire   +3 more sources

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Coupling of stemness maintenance with cell cycle control in stem cells. [PDF]

open access: yesFront Cell Dev Biol
Huang X, Wang Y, Li Q, Li X, Wang C.
europepmc   +1 more source

Cell cycle proteins in benign laryngeal lesions

open access: hybrid, 2008
Kamal Morshed   +7 more
openalex   +1 more source

Ctp1 Is a Cell-Cycle-Regulated Protein that Functions with Mre11 Complex to Control Double-Strand Break Repair by Homologous Recombination [PDF]

open access: bronze, 2007
Oliver Limbo   +5 more
openalex   +1 more source

Cell Cycle Control.

open access: yesNippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 1998
openaire   +3 more sources

TREX1, a predator for treating MSI‐H tumors?

open access: yesMolecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy